Strs Ohio Uro Gen Pharma Ltd. Transaction History

Strs Ohio

$26.2 Billion
Q3 2025

A detailed history of Strs Ohio transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Strs Ohio holds 3,800 shares of URGN stock, worth $92,454. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,800

Holding current value

$92,454

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	BUY	$12.96 - $21.42 $49,248 - $81,396	3,800 New	3,800 $74,000
Q3 2019 Oct 21, 2019	SELL	$23.83 - $36.44 $119,149 - $182,200	-5,000 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$32.75 - $40.35 $163,750 - $201,750	5,000 New	5,000 $179,000

Others Institutions Holding URGN

# of Institutions

170

Shares Held

44.1M

Call Options Held

1.61M

Put Options Held

433K

Rtw Investments, LP New York, NY

4.54M
Shares

$111 Million
1.19% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.22M
Shares

$103 Million
2.65% of portfolio
Toronto Dominion Bank Toronto, Ontario, A6

3.19M
Shares

$77.6 Million
0.1% of portfolio
Morgan Stanley New York, NY

2.53M
Shares

$61.5 Million
0.0% of portfolio
Jefferies Financial Group Inc. New York, NY

2.2M
Shares

$53.5 Million
0.21% of portfolio

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $553M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account